In both peripheral blood and peritoneal fluid, the percentage of CD4+ lymphocytes expressing IL-17 was significantly lower (p < 0.0001) in the ovarian cancer group than in the benign ovarian tumor group (Figure 3). Here, IL17A is linked to ovarian cancer.